Early treatment is ESSENTIAL to a good outcome (this is critical)

3. COVID-19 is a treatable disease; it is inappropriate to limit therapy to “supportive care” alone. Furthermore, it is likely that there will not be a single “magic bullet” to treat COVID-19. Rather, we should be using multiple drugs/interventions that have synergistic and overlapping biological effects that are safe, cheap and “readily” available. The impact of COVID-19 on middle- and lowincome countries will be enormous; these countries will not be able to afford expensive designer molecules. 4. The pulmonary phase

11. For prophylaxis and treatment of the early symptomatic phase, we suggest the combination of Quercetin (a plant polyphenol), Vitamin C and Zinc. This is based on intriguing basic-science data, which indicates that: a. Zinc is essential for innate and adaptive immunity.[9] In addition, Zinc inhibits RNA dependent RNA polymerase in vitro against SARS-CoV-2 virus.[8] b. Quercetin has direct viricidal properties against a range of viruses, including SARS-CoV2.[2,6] In addition, quercetin acts as a zinc ionophore. [137] c. Vitamin C improves the potency of Quercetin and its antiviral activity.[2]

12. It should also be noted that Vitamin D may be a very powerful prophylactic and treatment strategy against COVID-19. [17-24] Vitamin D deficiency explains, in part, the enormous geographic variation in mortality of this disease.